Related references
Note: Only part of the references are listed.Development and application of ultrasound contrast agents in biomedicine
Yu Wang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2021)
Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy
Weijing Yang et al.
ACS NANO (2020)
Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy
Hongzhang Deng et al.
NANO LETTERS (2020)
Synthesis of nanobubbles for improved ultrasound tumor-imaging applications
Juanjuan Zhang et al.
3 BIOTECH (2020)
NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
Ge Qin et al.
NATURE COMMUNICATIONS (2020)
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer
Fahad Shabbir Ahmed et al.
CLINICAL CANCER RESEARCH (2020)
Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin
Prachya Kongtawelert et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Enhancing cancer immunotherapy with nanomedicine
Darrell J. Irvine et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Immuno-oncology drug development goes global
Jia Xin Yu et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Engineering of a novel subnanomolar affinity fibronectin III domain binder targeting human programmed death-ligand 1
Sindhuja Ramakrishnan et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2019)
A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues
Arutselvan Natarajan et al.
CLINICAL CANCER RESEARCH (2019)
Nano-lipospheres as acoustically active ultrasound contrast agents: evolving tumor imaging and therapy technique
Laura Emma Andrews et al.
NANOTECHNOLOGY (2019)
Synthesis and Biologic Evaluation of a Novel F-18-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression
David J. Donnelly et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Immuno-Oncology: Emerging Targets and Combination Therapies
Henry T. Marshall et al.
FRONTIERS IN ONCOLOGY (2018)
Pipe Phantoms With Applications in Molecular Imaging and System Characterization
Shiying Wang et al.
IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL (2017)
Multiplex three-dimensional optical mapping of tumor immune microenvironment
Steve Seung-Young Lee et al.
SCIENTIFIC REPORTS (2017)
A review of the development of tumor vasculature and its effects on the tumor microenvironment
Jake Forster et al.
HYPOXIA (2017)
Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects
Hongyan Jia et al.
DRUG RESISTANCE UPDATES (2017)
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
Ashley Cimino-Mathews et al.
HUMAN PATHOLOGY (2016)
CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity
Melanie Straub et al.
ONCOTARGET (2016)
Ultrasound imaging beyond the vasculature with new generation contrast agents
Reshani H. Perera et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
Sofia Lyford-Pike et al.
CANCER RESEARCH (2013)
Use of 64Cu-labeled Fibronectin Domain with EGFR-Overexpressing Tumor Xenograft: Molecular Imaging
Benjamin J. Hackel et al.
RADIOLOGY (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Phase I and Pharmacokinetic Study of CT-322 (BMS-844203), a Targeted Adnectin Inhibitor of VEGFR-2 Based on a Domain of Human Fibronectin
Anthony W. Tolcher et al.
CLINICAL CANCER RESEARCH (2011)
Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
Christian Zahnd et al.
CANCER RESEARCH (2010)
Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery
Ye Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Prognostic value of microvessel density in prostate cancer: a tissue microarray study
Andreas Erbersdobler et al.
WORLD JOURNAL OF UROLOGY (2010)
High-affinity single-domain binding proteins with a binary-code interface
Akiko Koide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Influence of bubble size distribution on the echogenicity of ultrasound contrast agents -: A study of SonoVue™
JM Gorce et al.
INVESTIGATIVE RADIOLOGY (2000)
Share Paper
